Skip to main content
. 2017 May 3;8(28):46204–46210. doi: 10.18632/oncotarget.17581

Figure 2. Prognostic significance of TILs in relation to p16 status of the primary tumor.

Figure 2

(A) CD4+; (B) CD56+; (C) CD68+.